MYPLAN - Effectiveness of a Safety Plan App to Manage Crisis of Persons at Risk of Suicide
NCT ID: NCT02877316
Last Updated: 2023-10-10
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
546 participants
Study Classification
INTERVENTIONAL
Study Start Date
2016-10-31
Study Completion Date
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Background: Persons with a past episode of self-harm or severe suicidal ideation are at elevated risk of self-harm as well as dying by suicide. It is well established that suicidal ideation fluctuates over time. Safety plans in paper format are mandatory part of the treatment regime in the suicide preventive clinics in Denmark. The aim of the trial is to compare the paper version of the safety plan with a new-developed app in reducing suicide ideation and other symptoms, as an add-on to the supportive psychotherapy delivered in the clinics.
Hypothesis: It is hypothesized that participants randomized to MYPLAN will have lower suicide ideation as well as improvements on the secondary outcomes than users who have the paper version.
Methods: The trial is designed as a 2-arm observer-blinded parallel group randomized clinical superiority trial, where participants will either receive: 1) Experimental intervention: the safety plan provided as the app MYPLAN, or 2) Treatment as Usual: the safety plan in the original paper format. Both intervention groups will also receive standard psychosocial therapeutic care, up to 8-10 sessions of supportive psychotherapy.Based on a power calculation a total of 546 participants, 273 in each arm will be included. They will be recruited from national suicide preventive clinics. Follow-ups will be conducted at 3, 6, 9, and 12 months after date of inclusion.
Participants, inclusion and exclusion criteria: There is no age restriction on participation in the study and all participants will be recruited from the suicide prevention clinics in Denmark. These clinics are highly specialized outpatient care centers, offering short-term supportive psychotherapy and social counselling for suicidal patients. In order to participate in the study, participants must have a smartphone (IPhone or android phone) and understand sufficient Danish to use MYPLAN. Persons having a particularly severe alcohol or substance abuse disorder, which might inflict with skills of orientation and memorywill not be offered participation in the RCT.
Outcomes Patient reported outcomes (PROM) are collected at baseline and follow-up through self-administered tablet/internet-based questionnaires. Primary outcome is suicide ideation. Secondary outcomes are:, hopelessness, depressive symptoms, quality of life, and modified CSQ-8.
Statistical analysis: Data analysis will be based on intention-to-treat principle. We will examine this using repeated measurement in mixed models. Missing data will be handled with multiple imputations.
The trial will start in November 2016 and patient recruitment is expected to finish November 2017. Analysis and results are expected in 2018.
Hypothesis: It is hypothesized that participants randomized to MYPLAN will have lower suicide ideation as well as improvements on the secondary outcomes than users who have the paper version.
Methods: The trial is designed as a 2-arm observer-blinded parallel group randomized clinical superiority trial, where participants will either receive: 1) Experimental intervention: the safety plan provided as the app MYPLAN, or 2) Treatment as Usual: the safety plan in the original paper format. Both intervention groups will also receive standard psychosocial therapeutic care, up to 8-10 sessions of supportive psychotherapy.Based on a power calculation a total of 546 participants, 273 in each arm will be included. They will be recruited from national suicide preventive clinics. Follow-ups will be conducted at 3, 6, 9, and 12 months after date of inclusion.
Participants, inclusion and exclusion criteria: There is no age restriction on participation in the study and all participants will be recruited from the suicide prevention clinics in Denmark. These clinics are highly specialized outpatient care centers, offering short-term supportive psychotherapy and social counselling for suicidal patients. In order to participate in the study, participants must have a smartphone (IPhone or android phone) and understand sufficient Danish to use MYPLAN. Persons having a particularly severe alcohol or substance abuse disorder, which might inflict with skills of orientation and memorywill not be offered participation in the RCT.
Outcomes Patient reported outcomes (PROM) are collected at baseline and follow-up through self-administered tablet/internet-based questionnaires. Primary outcome is suicide ideation. Secondary outcomes are:, hopelessness, depressive symptoms, quality of life, and modified CSQ-8.
Statistical analysis: Data analysis will be based on intention-to-treat principle. We will examine this using repeated measurement in mixed models. Missing data will be handled with multiple imputations.
The trial will start in November 2016 and patient recruitment is expected to finish November 2017. Analysis and results are expected in 2018.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Randomized Trial
NCT05202756
Suicide and Self-harm
Suicide
Suicide, Attempted
+1 more
COMPLETED
NA
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Open Trial
NCT05180383
Suicide and Self-harm
Suicide
Suicide, Attempted
+1 more
COMPLETED
NA
Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
NCT07325474
Suicide Ideation
Suicide Attempt
NOT_YET_RECRUITING
NA
Electronic, Self-Guided Safety Plan in Adolescents: Project SAFER
NCT06868407
Suicide Attempt
Suicide Ideation
NOT_YET_RECRUITING
NA
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial
NCT05180331
Suicide
Suicide and Self-harm
Suicide, Attempted
+1 more
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
MYPLAN -mobile phone application to manage crisis of persons at risk of suicide:
a multi-center, superiority randomized clinical trial.
Andreasson K, Krogh J, Frandsen H, Buus N, Bech. P Nordentoft M, Erlangsen A Background
In Denmark, there are 8-10,000 people who attempt suicide on a yearly basis1. Suicide ideation is a part of a continuum, where initial suicidal ideation might develop into concrete plans and actions, depending on the suicidal intent suicidal actions might end as suicide attempts or completed suicide2 . Therefore, in order to prevent suicidal behavior and suicides, it is important to avoid or reduce suicide ideation; i.e. securing better control of painful thoughts and the suicidal behavior. This can be done with a safety plan. The safety plan has been developed as a cognitive therapeutic intervention applied empirically in some earlier studies 345. The safety plan can be considered as a part of a cognitive behavior therapeutic intervention, which reduces the suicidal risk and consists of basic components, such as 1) recognizing warning signs of an upcoming suicidal crisis, 2) work with internal coping strategies, 3) distraction from suicidal thoughts, by the use of social contacts and social settings6. This can be done by removing assess of lethal means, and self-monitoring the triggers of the "suicidal mode"7.
To prevent suicidal behavior, The National Board of Health has established Suicide Prevention Clinics nationwide in Denmark. The clinics offering highly specialized short-term supportive psychotherapy and social counselling for suicidal patients in an outpatient setting. The target group is a subsample of all persons with severe suicide ideation or suicide attempts as the clinics focus on persons at risk of suicide who do not have severe underlying psychiatric disorders that required psychiatric admission or specialized treatment8. Some clinics are specialized in children and adolescents and will offer support patients young as 10 years of age. The safety plan is an integral part of the treatment and all patient works with during the first sessions.
Hypothesis The hypothesis of this trial is that an app-based safety plan is more effective than a paper version of a safety plan in reducing suicide ideations in suicidal patients.
Purpose
The purpose of this trial is to investigate if a safety plan delivered as an app compared to a safety plan delivered by paper, can reduce suicide ideation after 12 months intervention in patients referred to Suicide Prevention Clinics.
Methods/design
The trial is designed as a 2-arm, multi-site, parallel group, observer-blinded randomized clinical superiority trial. Based on a power calculation, a total of 546 participants, 273 in each arm will be included, recruited from national suicide preventive clinics. Both groups will receive treatment as usual consisting of short term psychotherapy and social counselling: 1) Experimental intervention the safety plan provided as the app MYPLAN, or 2) Treatment as Usual (TAU): the safety plan in the original paper format.
Recruitment and criteria for inclusion and exclusion
All participants will be recruited through the Suicide Prevention Clinics in Denmark. The patients are referred from somatic and psychiatric wards after suicide attempts, general practitioners, and can also refer themselves to the suicide preventive clinics. There is no age restriction on participation in the study.
Enrollment and randomization
At the first visits at the Suicide Prevention Clinic, eligible participants will receive oral and information about the study as well as an information pamphlet. They will be offered time for reflection and possibility to have renewed appointment at the clinic together with a relative, before answering. If the patient fulfils all the inclusions criteria and none of the exclusion criteria, the patient will be randomized using a computer-generated sequence randomization to either 1) Treatment as usual plus app: treatment as usual plus the safety plan app, or 2) treatment as usual pus safety plan on paper. The randomization will be stratified by gender and previous self-harm (yes/no), and will be facilitated through an external, centrally administered internet service. The clinician working the Suicide Prevention Clinics, will by accessing the internet obtain information on the patients allocation (safety plan either as an app or paper version), immediately after the patients has provided informed consent. This procedure will ensure adequate allocation concealment.
Blinding Due to the nature of the intervention, a blinding of participants and clinicians is not possible, but outcome assessment and analyses will be carried out with blinding of treatment allocation. All data will be collected through questionnaires (SurveyXact) secured on an encrypted server. The analyses will be performed by blinded scientists.
Interventions Treatment as Usual (TAU): Participants allocated to the treatment at usual will receive up to 8-10 sessions of supportive psychotherapy as part of the standard care of the suicide preventive clinics. Each of the clinics apply different or combined therapies including cognitive, problem-solving, crisis, dialectical behavior, integrated care, psychodynamic, systemic, psychoanalytic approaches, and/or social counselling. A uniform treatment algorithm is not followed; elements are chosen on the basis of what is deemed the most promising strategy in each individual case. As an integral part of the therapy the clinical fill in a safety plan with the patient by reviewing what are signs of situations where crises occur and what has previously worked as strategies of distraction as well as help-seeking. The safety plan is presented to the patient using a comparable manual-based instruction. Participants randomized to the paper format will write the safety plan on a sheet of paper and bring home the original while the clinical keeps a copy together with the medical records of the patient.
Experimental intervention: Participants allocated to the experimental intervention will receive the treatment as usual, and have an introduction to the app-based safety plan MYPLAN. Using the instruction manual, the clinician will review previous crisis situations and possible strategies.
See figure 1. CONSORT flow diagram
Outcomes
Primary outcome will be measured as the difference in suicide ideation before entering the trial and after 12 month participation in the trial. This is measured by Becks suicide ideation scale (BSS 21-items). The outcome is considered as a proxy measure for suicide attempt and completed suicide.
Secondary outcomes are: hopelessness (Becks Hopelessness Scale, BHS), depressive symptoms (Major depression Inventory, MDI).
Exploratory outcomes We have chosen some exploratory outcomes such as, quality of life measured by WHO Well-being Index, (WHO-5), user satisfaction will be measured by modified User satisfaction Client Satisfaction Questionnaire (CSQ-8), self-harm (self-reported), mortality, admission to psychiatric or somatic emergency wards, and other somatic and psychiatric hospital registers data.
Patient reported outcomes measures (PROM) These are collected at baseline and follow-up through self-administered tablet-/ internet-based questionnaires. Follow-ups will be conducted at 3, 6, 9, and 12 months after date of inclusion. Participants will receive an e-mail with a link to an online survey. Respondents can log on to a secure data portal, SurveyXact, with their personal trial id-number and answers to questionnaires are collected.
The register-based outcomes such as mortality, suicide attempt, somatic and usage of somatic and mental health care services will be assessed at 12 and 24 months by obtaining data extract from above listed registries.
Statistical analysis
The primary outcome is the mean change in Becks Suicide Ideation scale at 6 months. We expect that participants in the intervention group at 6 months score 2.5 points lower compared to participants in the TAU group. Based on previous publication we expect a post-intervention SD of 9. Setting the alpha level to 5 percent and the beta level to 10 percent we need to include 273 participants for each group to a total of 546 participants.
Analysis of the primary outcome will be conducted according to intention-to-treat principle: all participants will be included in final analysis according to group assignment regardless of adherence to treatment. This study has multiple assessment points and for the primary analysis we will use repeated measurements in a mixed model with unstructured variance. This procedure is able to handle baseline differences and missing data. For participants with missing data in two or more data points we will identify potential differences to participants with full data and use include these variables as potential confounders in secondary analysis.
All statistical analysis will be conducted in SPSS. All tests will be two-tailed and p values below 0.5 will be considered significant and interpreted with respect to hierarchy of hypothesis.
Pilot study/feasibility test
Prior to study being a pilot study will be carried out in one of the sites. The aim is to make the pilot study as similar to the trial as possible. A total of 40 participant will be recruited, 20 in each arm. The randomization and other technical and practical procedures will be tested. Clinicians will present the safety plan as described above using a manual-based instruction. The participants will be followed for 3 months. Data on all scales listed as outcomes will be collected; at the time of enrollment by tablet and at end of follow-up by email.
Ethical considerations The trial will be approved by the Regional Ethics Committee in the Capital Region of Denmark and the Danish Data Protection agency. The trial is registered under Clinicaltrials.gov as NCT. In accordance to with the Consort guidelines, we will publish positive, neutral and negatives findings in the trial. The patients will be informed about the trial both verbally and written information before signing the written consent. They are offered time for consideration and they can have a renew appointment together with a spouse, before signing the written consent. It will be stressed that participation are voluntary. Participation and the written consent can be withdrawn at any time.
Organization and economy The trial is led by postdoctoral researcher Kate Andreasson Aamund, Psychiatric Centre North Zealand in close collaboration with Danish Research Institute for Suicide Prevention (DRIPS), Mental Health Center Copenhagen and the Suicide Prevention Clinics. The patient recruitment will be done through the Danish Suicide Prevention Clinics in Denmark. The project has received funding from the Danish non-profit foundation (TrygFonden).
Analyses and results are expected in summer 2018
a multi-center, superiority randomized clinical trial.
Andreasson K, Krogh J, Frandsen H, Buus N, Bech. P Nordentoft M, Erlangsen A Background
In Denmark, there are 8-10,000 people who attempt suicide on a yearly basis1. Suicide ideation is a part of a continuum, where initial suicidal ideation might develop into concrete plans and actions, depending on the suicidal intent suicidal actions might end as suicide attempts or completed suicide2 . Therefore, in order to prevent suicidal behavior and suicides, it is important to avoid or reduce suicide ideation; i.e. securing better control of painful thoughts and the suicidal behavior. This can be done with a safety plan. The safety plan has been developed as a cognitive therapeutic intervention applied empirically in some earlier studies 345. The safety plan can be considered as a part of a cognitive behavior therapeutic intervention, which reduces the suicidal risk and consists of basic components, such as 1) recognizing warning signs of an upcoming suicidal crisis, 2) work with internal coping strategies, 3) distraction from suicidal thoughts, by the use of social contacts and social settings6. This can be done by removing assess of lethal means, and self-monitoring the triggers of the "suicidal mode"7.
To prevent suicidal behavior, The National Board of Health has established Suicide Prevention Clinics nationwide in Denmark. The clinics offering highly specialized short-term supportive psychotherapy and social counselling for suicidal patients in an outpatient setting. The target group is a subsample of all persons with severe suicide ideation or suicide attempts as the clinics focus on persons at risk of suicide who do not have severe underlying psychiatric disorders that required psychiatric admission or specialized treatment8. Some clinics are specialized in children and adolescents and will offer support patients young as 10 years of age. The safety plan is an integral part of the treatment and all patient works with during the first sessions.
Hypothesis The hypothesis of this trial is that an app-based safety plan is more effective than a paper version of a safety plan in reducing suicide ideations in suicidal patients.
Purpose
The purpose of this trial is to investigate if a safety plan delivered as an app compared to a safety plan delivered by paper, can reduce suicide ideation after 12 months intervention in patients referred to Suicide Prevention Clinics.
Methods/design
The trial is designed as a 2-arm, multi-site, parallel group, observer-blinded randomized clinical superiority trial. Based on a power calculation, a total of 546 participants, 273 in each arm will be included, recruited from national suicide preventive clinics. Both groups will receive treatment as usual consisting of short term psychotherapy and social counselling: 1) Experimental intervention the safety plan provided as the app MYPLAN, or 2) Treatment as Usual (TAU): the safety plan in the original paper format.
Recruitment and criteria for inclusion and exclusion
All participants will be recruited through the Suicide Prevention Clinics in Denmark. The patients are referred from somatic and psychiatric wards after suicide attempts, general practitioners, and can also refer themselves to the suicide preventive clinics. There is no age restriction on participation in the study.
Enrollment and randomization
At the first visits at the Suicide Prevention Clinic, eligible participants will receive oral and information about the study as well as an information pamphlet. They will be offered time for reflection and possibility to have renewed appointment at the clinic together with a relative, before answering. If the patient fulfils all the inclusions criteria and none of the exclusion criteria, the patient will be randomized using a computer-generated sequence randomization to either 1) Treatment as usual plus app: treatment as usual plus the safety plan app, or 2) treatment as usual pus safety plan on paper. The randomization will be stratified by gender and previous self-harm (yes/no), and will be facilitated through an external, centrally administered internet service. The clinician working the Suicide Prevention Clinics, will by accessing the internet obtain information on the patients allocation (safety plan either as an app or paper version), immediately after the patients has provided informed consent. This procedure will ensure adequate allocation concealment.
Blinding Due to the nature of the intervention, a blinding of participants and clinicians is not possible, but outcome assessment and analyses will be carried out with blinding of treatment allocation. All data will be collected through questionnaires (SurveyXact) secured on an encrypted server. The analyses will be performed by blinded scientists.
Interventions Treatment as Usual (TAU): Participants allocated to the treatment at usual will receive up to 8-10 sessions of supportive psychotherapy as part of the standard care of the suicide preventive clinics. Each of the clinics apply different or combined therapies including cognitive, problem-solving, crisis, dialectical behavior, integrated care, psychodynamic, systemic, psychoanalytic approaches, and/or social counselling. A uniform treatment algorithm is not followed; elements are chosen on the basis of what is deemed the most promising strategy in each individual case. As an integral part of the therapy the clinical fill in a safety plan with the patient by reviewing what are signs of situations where crises occur and what has previously worked as strategies of distraction as well as help-seeking. The safety plan is presented to the patient using a comparable manual-based instruction. Participants randomized to the paper format will write the safety plan on a sheet of paper and bring home the original while the clinical keeps a copy together with the medical records of the patient.
Experimental intervention: Participants allocated to the experimental intervention will receive the treatment as usual, and have an introduction to the app-based safety plan MYPLAN. Using the instruction manual, the clinician will review previous crisis situations and possible strategies.
See figure 1. CONSORT flow diagram
Outcomes
Primary outcome will be measured as the difference in suicide ideation before entering the trial and after 12 month participation in the trial. This is measured by Becks suicide ideation scale (BSS 21-items). The outcome is considered as a proxy measure for suicide attempt and completed suicide.
Secondary outcomes are: hopelessness (Becks Hopelessness Scale, BHS), depressive symptoms (Major depression Inventory, MDI).
Exploratory outcomes We have chosen some exploratory outcomes such as, quality of life measured by WHO Well-being Index, (WHO-5), user satisfaction will be measured by modified User satisfaction Client Satisfaction Questionnaire (CSQ-8), self-harm (self-reported), mortality, admission to psychiatric or somatic emergency wards, and other somatic and psychiatric hospital registers data.
Patient reported outcomes measures (PROM) These are collected at baseline and follow-up through self-administered tablet-/ internet-based questionnaires. Follow-ups will be conducted at 3, 6, 9, and 12 months after date of inclusion. Participants will receive an e-mail with a link to an online survey. Respondents can log on to a secure data portal, SurveyXact, with their personal trial id-number and answers to questionnaires are collected.
The register-based outcomes such as mortality, suicide attempt, somatic and usage of somatic and mental health care services will be assessed at 12 and 24 months by obtaining data extract from above listed registries.
Statistical analysis
The primary outcome is the mean change in Becks Suicide Ideation scale at 6 months. We expect that participants in the intervention group at 6 months score 2.5 points lower compared to participants in the TAU group. Based on previous publication we expect a post-intervention SD of 9. Setting the alpha level to 5 percent and the beta level to 10 percent we need to include 273 participants for each group to a total of 546 participants.
Analysis of the primary outcome will be conducted according to intention-to-treat principle: all participants will be included in final analysis according to group assignment regardless of adherence to treatment. This study has multiple assessment points and for the primary analysis we will use repeated measurements in a mixed model with unstructured variance. This procedure is able to handle baseline differences and missing data. For participants with missing data in two or more data points we will identify potential differences to participants with full data and use include these variables as potential confounders in secondary analysis.
All statistical analysis will be conducted in SPSS. All tests will be two-tailed and p values below 0.5 will be considered significant and interpreted with respect to hierarchy of hypothesis.
Pilot study/feasibility test
Prior to study being a pilot study will be carried out in one of the sites. The aim is to make the pilot study as similar to the trial as possible. A total of 40 participant will be recruited, 20 in each arm. The randomization and other technical and practical procedures will be tested. Clinicians will present the safety plan as described above using a manual-based instruction. The participants will be followed for 3 months. Data on all scales listed as outcomes will be collected; at the time of enrollment by tablet and at end of follow-up by email.
Ethical considerations The trial will be approved by the Regional Ethics Committee in the Capital Region of Denmark and the Danish Data Protection agency. The trial is registered under Clinicaltrials.gov as NCT. In accordance to with the Consort guidelines, we will publish positive, neutral and negatives findings in the trial. The patients will be informed about the trial both verbally and written information before signing the written consent. They are offered time for consideration and they can have a renew appointment together with a spouse, before signing the written consent. It will be stressed that participation are voluntary. Participation and the written consent can be withdrawn at any time.
Organization and economy The trial is led by postdoctoral researcher Kate Andreasson Aamund, Psychiatric Centre North Zealand in close collaboration with Danish Research Institute for Suicide Prevention (DRIPS), Mental Health Center Copenhagen and the Suicide Prevention Clinics. The patient recruitment will be done through the Danish Suicide Prevention Clinics in Denmark. The project has received funding from the Danish non-profit foundation (TrygFonden).
Analyses and results are expected in summer 2018
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Suicide Prevention
Suicidal Thoughts
Suicide Attempts
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
PREVENTION
Blinding Strategy
SINGLE
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MYPLAN app
MYPLAN app (safety plan) as part of treatment
Group Type
EXPERIMENTAL
MYPLAN-safety plan as an application for smart phones
Intervention Type
OTHER
MYPLAN app as a integral part of the standard treatment
Safety plan on paper
Safety plan on paper as part of treatment
Group Type
ACTIVE_COMPARATOR
safety plan on paper
Intervention Type
OTHER
Standard treatment with safety plan on paper
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MYPLAN-safety plan as an application for smart phones
MYPLAN app as a integral part of the standard treatment
Intervention Type
OTHER
safety plan on paper
Standard treatment with safety plan on paper
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smart phone (Iphone/android)
* Understand sufficient Danish to use MYPLAN
* Informed written consent
* Understand sufficient Danish to use MYPLAN
* Informed written consent
Exclusion Criteria
* Alcohol or substance abuse disorder (DSM-V)
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mental Health Services in the Capital Region, Denmark
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Aamund
MD, postdoctoral researcher
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merete Nordentoft, MD, Ph.D MSc
Role: STUDY_CHAIR
Mental Health Center Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychiatric centre Ballerup, Clinic for psychoterapy
Ballerup Municipality, , Denmark
Site Status
Competence centre for suicide prevention
Copenhagen, , Denmark
Site Status
Psychiatric Centre North Zealand
Hillerød, , Denmark
Site Status
Clinic for suicide prevention
Køge, , Denmark
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Denmark
References
Explore related publications, articles, or registry entries linked to this study.
Christiansen E, Jensen BF. Register for Suicide Attempts. Dan Med Bull. 2004 Nov;51(4):415-7.
Reference Type
BACKGROUND
Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA. 2005 Aug 3;294(5):563-70. doi: 10.1001/jama.294.5.563.
Reference Type
BACKGROUND
Stanley B, Brown G, Brent DA, Wells K, Poling K, Curry J, Kennard BD, Wagner A, Cwik MF, Klomek AB, Goldstein T, Vitiello B, Barnett S, Daniel S, Hughes J. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1005-1013. doi: 10.1097/CHI.0b013e3181b5dbfe.
Reference Type
BACKGROUND
Yanos PT, Stanley BS, Greene CS. Research risk for persons with psychiatric disorders: a decisional framework to meet the ethical challenge. Psychiatr Serv. 2009 Mar;60(3):374-83. doi: 10.1176/ps.2009.60.3.374.
Reference Type
BACKGROUND
Erlangsen A, Lind BD, Stuart EA, Qin P, Stenager E, Larsen KJ, Wang AG, Hvid M, Nielsen AC, Pedersen CM, Winslov JH, Langhoff C, Muhlmann C, Nordentoft M. Short-term and long-term effects of psychosocial therapy for people after deliberate self-harm: a register-based, nationwide multicentre study using propensity score matching. Lancet Psychiatry. 2015 Jan;2(1):49-58. doi: 10.1016/S2215-0366(14)00083-2. Epub 2015 Jan 8.
Reference Type
BACKGROUND
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev. 2021 Mar 7;3(3):CD013667. doi: 10.1002/14651858.CD013667.pub2.
Reference Type
DERIVED
Andreasson K, Krogh J, Bech P, Frandsen H, Buus N, Stanley B, Kerkhof A, Nordentoft M, Erlangsen A. MYPLAN -mobile phone application to manage crisis of persons at risk of suicide: study protocol for a randomized controlled trial. Trials. 2017 Apr 11;18(1):171. doi: 10.1186/s13063-017-1876-9.
Reference Type
DERIVED
Related Links
Access external resources that provide additional context or updates about the study.
http://www.apa.org/pubs/books/4317169.aspx
Ref. 5. Cognitive therapy for suicidal patients
http://www.hup.harvard.edu/catalog.php?isbn=9780674025493
Ref 7. Why people die by suicide
https://www.psychiatry.org/psychiatrists/practice/dsm
Ref. 9. Diagnostic and statistical manual of mental health disorders
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHSCRDenmark
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial (2)
NCT05180344
RECRUITING
NA
Development of a Video-based Intervention for Suicide Prevention
NCT04307394
COMPLETED
NA
Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts
NCT05791643
COMPLETED
NA
Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care
NCT05282225
ACTIVE_NOT_RECRUITING
NA
The Amager Project: Intervention After Suicide Attempt
NCT00821756
UNKNOWN
NA
Evaluation of the Safety Plan to Prevent Suicidal Reiteration
NCT05609487
RECRUITING
NA
Written vs Electronic Safety Planning Study
NCT04026308
COMPLETED
NA
Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff
NCT02981420
UNKNOWN
NA
Pilot RCT of a Video-based Intervention for Suicide Prevention
NCT05127330
COMPLETED
NA
Safety Planning in Juvenile Justice for Suicidal Youth
NCT03655470
COMPLETED
NA
Study About Treatment After a Suicide Attempt
NCT03894462
COMPLETED
NA
Family Intervention for Suicidal Youth: Emergency Care
NCT00558805
COMPLETED
PHASE2
An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART
NCT03838198
COMPLETED
NA
Efficacy of a Smartphone Suicide Prevention App
NCT07160465
NOT_YET_RECRUITING
NA
Implementation of Suicide Risk Models in Health Systems
NCT06060535
ENROLLING_BY_INVITATION
NA
Mobile Technology for Reducing and Preventing Adolescent Suicide
NCT04896593
COMPLETED
NA
Study for the Use Smartphone Application to Prevent Suicidal Relapse Among 15-35 Years-old With Previous Suicide Attempted
NCT03975881
UNKNOWN
NA
Zero Self-Harm - a Mobile Phone Application to Reduce Non-suicidal Self-injury
NCT04463654
COMPLETED
NA
AID-trial Assertive Intervention After Deliberate Self-harm
NCT00700089
COMPLETED
PHASE4
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury
NCT07224165
NOT_YET_RECRUITING
NA
Evaluation of an App for Young People With Suicidal Thoughts
NCT07165561
RECRUITING
NA
Ottawa Suicide Prevention in Men Pilot Study
NCT02718248
COMPLETED
NA
Integrated Suicide Supports and Safety Planning for Youth
NCT06701006
RECRUITING
NA
Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide
NCT02985047
COMPLETED
NA
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
NCT05423483
COMPLETED
PHASE2